[
  {
    "title": "仁和药业四季度迎来转机 依靠核心竞争力把握“四类药品”发展机遇",
    "href": "http://stock.jrj.com.cn/2022/12/19093237221503.shtml",
    "datetime": "2022-12-19 09:32:51",
    "code": "000650"
  },
  {
    "title": "A股异动 | 仁和药业涨约8%突破阶段高价 拟5亿元投建中药产业园项目",
    "href": "http://stock.jrj.com.cn/2022/12/12142837205515.shtml",
    "datetime": "2022-12-12 14:28:21",
    "code": "000650"
  },
  {
    "title": "仁和药业(000650.SZ)：拟投资5亿元建药都里中药生态健康产业园项目",
    "href": "http://stock.jrj.com.cn/2022/12/09161737201660.shtml",
    "datetime": "2022-12-09 16:17:53",
    "code": "000650"
  },
  {
    "title": "仁和药业(000650.SZ)：终止“仁和翔鹤工业大麻综合利用产业项目”",
    "href": "http://stock.jrj.com.cn/2022/12/09161637201661.shtml",
    "datetime": "2022-12-09 16:16:25",
    "code": "000650"
  },
  {
    "title": "【龙虎榜】仁和药业12月7日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/12/07180137195629.shtml",
    "datetime": "2022-12-07 18:01:01",
    "code": "000650"
  },
  {
    "title": "仁和药业2022年前三季度净利4.56亿同比下滑13% 大额存单利息收入少",
    "href": "http://stock.jrj.com.cn/2022/10/25175037082252.shtml",
    "datetime": "2022-10-25 17:50:47",
    "code": "000650"
  },
  {
    "title": "仁和药业(000650.SZ)第三季度净利润1.56亿元 同比下降18.78%",
    "href": "http://stock.jrj.com.cn/2022/10/25154037081593.shtml",
    "datetime": "2022-10-25 15:40:58",
    "code": "000650"
  },
  {
    "title": "仁和药业总经理张威辞职 2021年薪酬为85.3万",
    "href": "http://stock.jrj.com.cn/2022/07/26195236844724.shtml",
    "datetime": "2022-07-26 19:52:20",
    "code": "000650"
  },
  {
    "title": "仁和药业：公司总经理张威、副总经理王甄辞职",
    "href": "http://stock.jrj.com.cn/2022/07/26135136843438.shtml",
    "datetime": "2022-07-26 13:51:33",
    "code": "000650"
  },
  {
    "title": "仁和药业：向江西省樟树市红十字会捐赠245万元 有助于提升公司社会形象和影响力",
    "href": "http://stock.jrj.com.cn/2022/06/06150836705603.shtml",
    "datetime": "2022-06-06 15:08:36",
    "code": "000650"
  },
  {
    "title": "仁和药业(000650.SZ)：向樟树市红十字会捐款245万元",
    "href": "http://stock.jrj.com.cn/2022/06/06120136705074.shtml",
    "datetime": "2022-06-06 12:01:34",
    "code": "000650"
  },
  {
    "title": "营销翻车，妇炎洁为“不尊重女性”道歉！背后仁和药业遭立案调查",
    "href": "http://stock.jrj.com.cn/2022/05/21143136667910.shtml",
    "datetime": "2022-05-21 14:31:50",
    "code": "000650"
  },
  {
    "title": "仁和药业(000650.SZ)2021年度权益分派10派1元 股权登记日为5月26日",
    "href": "http://stock.jrj.com.cn/2022/05/19175236662872.shtml",
    "datetime": "2022-05-19 17:52:38",
    "code": "000650"
  },
  {
    "title": "妇炎洁侮辱女性将被立案，仁和药业信披遭质疑，董事长杨潇刚上任",
    "href": "http://stock.jrj.com.cn/2022/05/19171136662590.shtml",
    "datetime": "2022-05-19 17:11:27",
    "code": "000650"
  },
  {
    "title": "妇炎洁打“情色擦边球”翻车，背后的仁和药业是啥来头？",
    "href": "http://stock.jrj.com.cn/2022/05/18230736660500.shtml",
    "datetime": "2022-05-18 23:07:55",
    "code": "000650"
  },
  {
    "title": "仁和药业翻车了，旗下妇炎洁广告被指侮辱女性，中国妇女报紧急出手，资金疯狂炒作永吉转债，中一签赚3千",
    "href": "http://stock.jrj.com.cn/2022/05/18160436658751.shtml",
    "datetime": "2022-05-18 16:04:10",
    "code": "000650"
  },
  {
    "title": "仁和药业子公司药品通过仿制药一致性评价：用作口服糖尿病治疗药物",
    "href": "http://stock.jrj.com.cn/2022/05/09161136606791.shtml",
    "datetime": "2022-05-09 16:11:41",
    "code": "000650"
  },
  {
    "title": "仁和药业(000650.SZ)：子公司格列齐特缓释片通过一致性评价",
    "href": "http://stock.jrj.com.cn/2022/05/09154236606698.shtml",
    "datetime": "2022-05-09 15:42:52",
    "code": "000650"
  },
  {
    "title": "仁和药业2022年第一季度净利1.56亿同比增长1.95% 理财产品取得收益",
    "href": "http://stock.jrj.com.cn/2022/05/03153236543696.shtml",
    "datetime": "2022-05-03 15:32:50",
    "code": "000650"
  },
  {
    "title": "仁和药业(000650.SZ)：一季度净利升1.95%至1.56亿元",
    "href": "http://stock.jrj.com.cn/2022/04/26161936475760.shtml",
    "datetime": "2022-04-26 16:19:02",
    "code": "000650"
  },
  {
    "title": "仁和药业2021年净利6.65亿同比增长14.62% 董事长杨潇薪酬36.33万",
    "href": "http://stock.jrj.com.cn/2022/04/26105236473227.shtml",
    "datetime": "2022-04-26 10:52:22",
    "code": "000650"
  },
  {
    "title": "仁和药业(000650.SZ)2021年度净利升14.62%至6.65亿元 拟10派1元",
    "href": "http://stock.jrj.com.cn/2022/04/25170636464429.shtml",
    "datetime": "2022-04-25 17:06:13",
    "code": "000650"
  },
  {
    "title": "仁和药业(000650.SZ)：拟使用不超3.5亿元暂时闲置募集资金进行现金管理",
    "href": "http://stock.jrj.com.cn/2021/12/21185134042752.shtml",
    "datetime": "2021-12-21 18:51:29",
    "code": "000650"
  },
  {
    "title": "仁和药业(000650.SZ)：第三季度净利升45.32%至1.92亿元",
    "href": "http://stock.jrj.com.cn/2021/10/27163233761787.shtml",
    "datetime": "2021-10-27 16:32:50",
    "code": "000650"
  },
  {
    "title": "仁和药业全资子公司吉安三力生产销售劣药被罚款 公司未披露相关信息",
    "href": "http://stock.jrj.com.cn/2021/10/22141633732917.shtml",
    "datetime": "2021-10-22 14:16:07",
    "code": "000650"
  },
  {
    "title": "仁和药业(000650.SZ)：拟以5787万元购买北京东城区的相关房产 作为自用办公场所",
    "href": "http://stock.jrj.com.cn/2021/09/29165833536908.shtml",
    "datetime": "2021-09-29 16:58:25",
    "code": "000650"
  },
  {
    "title": "仁和药业控费提效净利增35.71% 负债率低至11.38%加码大健康转型",
    "href": "http://stock.jrj.com.cn/2021/08/27074233330460.shtml",
    "datetime": "2021-08-27 07:42:36",
    "code": "000650"
  },
  {
    "title": "仁和药业2021年半年度净利3.29亿元 同比净利增加35.71%",
    "href": "http://stock.jrj.com.cn/2021/08/25170133317071.shtml",
    "datetime": "2021-08-25 17:01:36",
    "code": "000650"
  },
  {
    "title": "仁和药业(000650.SZ)上半年净利升35.71%至3.29亿元",
    "href": "http://stock.jrj.com.cn/2021/08/25164733316900.shtml",
    "datetime": "2021-08-25 16:47:38",
    "code": "000650"
  },
  {
    "title": "仁和药业：回购方案已实施完毕 累计回购1.4558%公司股份",
    "href": "http://stock.jrj.com.cn/2021/08/10170533232414.shtml",
    "datetime": "2021-08-10 17:05:22",
    "code": "000650"
  },
  {
    "title": "仁和药业(000650.SZ)：完成回购 累计耗资1.996亿元回购2038万股",
    "href": "http://stock.jrj.com.cn/2021/08/10155533231715.shtml",
    "datetime": "2021-08-10 15:55:27",
    "code": "000650"
  },
  {
    "title": "仁和药业(000650.SZ)：截至8月4日已回购1.04%股份",
    "href": "http://stock.jrj.com.cn/2021/08/04171933201861.shtml",
    "datetime": "2021-08-04 17:19:31",
    "code": "000650"
  },
  {
    "title": "仁和药业将花不超2亿元回购公司股份 用于股权激励",
    "href": "http://stock.jrj.com.cn/2021/07/26215333154126.shtml",
    "datetime": "2021-07-26 21:53:49",
    "code": "000650"
  },
  {
    "title": "仁和药业：拟1亿至2亿元回购股份 回购价格不超12元/股",
    "href": "http://stock.jrj.com.cn/2021/07/26202433153850.shtml",
    "datetime": "2021-07-26 20:24:23",
    "code": "000650"
  },
  {
    "title": "仁和药业(000650.SZ)：拟回购1亿元-2亿元股份",
    "href": "http://stock.jrj.com.cn/2021/07/26191433153449.shtml",
    "datetime": "2021-07-26 19:14:15",
    "code": "000650"
  },
  {
    "title": "仁和药业溢价9倍关联收购贴牌生产方 销售费为研发费14倍营收一半来自贴牌",
    "href": "http://stock.jrj.com.cn/2021/07/08072533062102.shtml",
    "datetime": "2021-07-08 07:25:23",
    "code": "000650"
  },
  {
    "title": "【龙虎榜】仁和药业7月7日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2021/07/07180133059193.shtml",
    "datetime": "2021-07-07 18:01:03",
    "code": "000650"
  },
  {
    "title": "仁和药业：拟71,949.60万元收购聚和电子商务等七家公司各80%股权",
    "href": "http://stock.jrj.com.cn/2021/07/06211333054749.shtml",
    "datetime": "2021-07-06 21:13:53",
    "code": "000650"
  },
  {
    "title": "仁和药业(000650.SZ)：拟以7.19亿元收购深圳三浦天然化妆品等7家公司各80%股权",
    "href": "http://stock.jrj.com.cn/2021/07/06175733053758.shtml",
    "datetime": "2021-07-06 17:57:48",
    "code": "000650"
  },
  {
    "title": "【龙虎榜】仁和药业7月5日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2021/07/05180033048166.shtml",
    "datetime": "2021-07-05 18:00:41",
    "code": "000650"
  },
  {
    "title": "【龙虎榜】仁和药业6月28日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2021/06/28180033010945.shtml",
    "datetime": "2021-06-28 18:00:31",
    "code": "000650"
  },
  {
    "title": "仁和药业：目前公司证券部暂时没有涉及口服玻尿酸相应产品后续研发的信息",
    "href": "http://stock.jrj.com.cn/2021/06/23192732984487.shtml",
    "datetime": "2021-06-23 19:27:31",
    "code": "000650"
  },
  {
    "title": "仁和药业：公司重视研发工作 公司的研发工作与公司的发展是呈正比的关系",
    "href": "http://stock.jrj.com.cn/2021/06/21170432970115.shtml",
    "datetime": "2021-06-21 17:04:49",
    "code": "000650"
  },
  {
    "title": "仁和药业：公司工业子公司樟树制药生产史国公药酒",
    "href": "http://stock.jrj.com.cn/2021/05/31151632849331.shtml",
    "datetime": "2021-05-31 15:16:18",
    "code": "000650"
  },
  {
    "title": "仁和药业一口气购7家公司加码大健康 10年逾14亿并购推动净利温和式增长",
    "href": "http://stock.jrj.com.cn/2021/05/27073332827037.shtml",
    "datetime": "2021-05-27 07:33:50",
    "code": "000650"
  },
  {
    "title": "【龙虎榜】仁和药业5月26日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2021/05/26180032824202.shtml",
    "datetime": "2021-05-26 18:00:50",
    "code": "000650"
  },
  {
    "title": "仁和药业：公司严格遵守国家相关的法律法规来种植、生产和经营工业大麻",
    "href": "http://stock.jrj.com.cn/2021/05/26090232821066.shtml",
    "datetime": "2021-05-26 09:02:55",
    "code": "000650"
  },
  {
    "title": "【龙虎榜】仁和药业5月25日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2021/05/25180032817292.shtml",
    "datetime": "2021-05-25 18:00:24",
    "code": "000650"
  },
  {
    "title": "丰富公司产品资源，仁和药业拟收购七家大健康相关企业80%股权",
    "href": "http://stock.jrj.com.cn/2021/05/25144032816344.shtml",
    "datetime": "2021-05-25 14:40:19",
    "code": "000650"
  },
  {
    "title": "A股异动 | 仁和药业(000650.SZ)触及涨停 拟收购三浦天然化妆品等七家公司股权",
    "href": "http://stock.jrj.com.cn/2021/05/25112632815662.shtml",
    "datetime": "2021-05-25 11:26:20",
    "code": "000650"
  },
  {
    "title": "医药界的“南极人”？仁和药业贴牌产品纠纷不断，打包收购大股东“关联”公司",
    "href": "http://stock.jrj.com.cn/2021/05/25110032815534.shtml",
    "datetime": "2021-05-25 11:00:00",
    "code": "000650"
  },
  {
    "title": "仁和药业拟收购七家标的公司各80%股份",
    "href": "http://stock.jrj.com.cn/2021/05/25070532814415.shtml",
    "datetime": "2021-05-25 07:05:00",
    "code": "000650"
  },
  {
    "title": "仁和药业(000650.SZ)：拟收购三浦天然化妆品等7家公司各80%股份",
    "href": "http://stock.jrj.com.cn/2021/05/24163332810906.shtml",
    "datetime": "2021-05-24 16:33:32",
    "code": "000650"
  },
  {
    "title": "仁和药业长高、生男“神器”牵出OEM乱象 四年仅一款仿制药获批一致性评价",
    "href": "http://stock.jrj.com.cn/2021/05/24073232805030.shtml",
    "datetime": "2021-05-24 07:32:06",
    "code": "000650"
  },
  {
    "title": "仁和药业(000650.SZ)2020年度权益分派10派2元 股权登记日为5月28日",
    "href": "http://stock.jrj.com.cn/2021/05/21183632794519.shtml",
    "datetime": "2021-05-21 18:36:16",
    "code": "000650"
  },
  {
    "title": "中药板块拉升，太极集团、仁和药业等多股涨停，机构推荐两条投资主线",
    "href": "http://stock.jrj.com.cn/2021/05/20095332785618.shtml",
    "datetime": "2021-05-20 09:53:24",
    "code": "000650"
  },
  {
    "title": "【龙虎榜】仁和药业5月18日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2021/05/18180032777004.shtml",
    "datetime": "2021-05-18 18:00:51",
    "code": "000650"
  },
  {
    "title": "【龙虎榜】仁和药业5月11日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2021/05/11180032736331.shtml",
    "datetime": "2021-05-11 18:00:13",
    "code": "000650"
  },
  {
    "title": "仁和药业(000650.SZ)一季度净利升45.38%至1.50亿元",
    "href": "http://stock.jrj.com.cn/2021/04/27212432465575.shtml",
    "datetime": "2021-04-27 21:24:10",
    "code": "000650"
  },
  {
    "title": "仁和药业2020年净利增长5.74% 董事长梅强薪酬73.9万",
    "href": "http://stock.jrj.com.cn/2021/04/23092732428393.shtml",
    "datetime": "2021-04-23 09:27:54",
    "code": "000650"
  },
  {
    "title": "仁和药业(000650.SZ)2020年净利升5.74%至5.69亿元 拟10派2元",
    "href": "http://stock.jrj.com.cn/2021/04/22160532423408.shtml",
    "datetime": "2021-04-22 16:05:24",
    "code": "000650"
  },
  {
    "title": "仁和药业2020年度净利5.69亿增长5.79% 毛利率增加",
    "href": "http://stock.jrj.com.cn/2021/04/13234232367603.shtml",
    "datetime": "2021-04-13 23:42:21",
    "code": "000650"
  },
  {
    "title": "仁和药业2021年第一季度预计净利1.39亿-1.6亿增长35%-55% 毛利率增加",
    "href": "http://stock.jrj.com.cn/2021/04/12193432359040.shtml",
    "datetime": "2021-04-12 19:34:25",
    "code": "000650"
  },
  {
    "title": "仁和药业(000650.SZ)业绩快报：2020年度净利润升5.79%至5.69亿元",
    "href": "http://stock.jrj.com.cn/2021/04/12192132358981.shtml",
    "datetime": "2021-04-12 19:21:23",
    "code": "000650"
  },
  {
    "title": "仁和药业(000650.SZ)一季度净利预增35.00%-55.00%",
    "href": "http://stock.jrj.com.cn/2021/04/12131732357165.shtml",
    "datetime": "2021-04-12 13:17:25",
    "code": "000650"
  },
  {
    "title": "江西药品抽检9批次不合规 仁和药业子公司产胶囊登榜",
    "href": "http://stock.jrj.com.cn/2021/03/31152332255936.shtml",
    "datetime": "2021-03-31 15:23:00",
    "code": "000650"
  },
  {
    "title": "仁和药业(000650.SZ)：恩替卡韦片获批上市",
    "href": "http://stock.jrj.com.cn/2021/03/25164132216272.shtml",
    "datetime": "2021-03-25 16:41:42",
    "code": "000650"
  },
  {
    "title": "仁和药业2020年预计净利5亿-5.38亿下降0%-7.02% 感冒药受疫情影响销售下降",
    "href": "http://stock.jrj.com.cn/2021/01/13203531686147.shtml",
    "datetime": "2021-01-13 20:35:29",
    "code": "000650"
  },
  {
    "title": "仁和药业(000650.SZ)：共有222个产品进入国家医保目录",
    "href": "http://stock.jrj.com.cn/2021/01/13154531684052.shtml",
    "datetime": "2021-01-13 15:45:46",
    "code": "000650"
  },
  {
    "title": "仁和药业(000650.SZ)：2020年净利预降0%-7.02% Q4净利预增32.30%-70.78%",
    "href": "http://stock.jrj.com.cn/2021/01/13115031682798.shtml",
    "datetime": "2021-01-13 11:50:22",
    "code": "000650"
  },
  {
    "title": "江西仁和中方公司违法销售劣药遭罚 为仁和药业子公司",
    "href": "http://stock.jrj.com.cn/2020/12/15174931495432.shtml",
    "datetime": "2020-12-15 17:49:00",
    "code": "000650"
  },
  {
    "title": "仁和药业(000650.SZ)披露定增报告书：发行对象最终确定为10家 包括易方达基金及中意资产",
    "href": "http://stock.jrj.com.cn/2020/11/18180331309111.shtml",
    "datetime": "2020-11-18 18:03:38",
    "code": "000650"
  },
  {
    "title": "仁和药业：拟向叮当快药转让仁和药房网45%股权 有利于公司优化战略布局",
    "href": "http://stock.jrj.com.cn/2020/11/13173931276444.shtml",
    "datetime": "2020-11-13 17:39:35",
    "code": "000650"
  },
  {
    "title": "仁和药业(000650.SZ)：拟使用最高额度不超4.5亿元暂时闲置募集资金进行现金管理",
    "href": "http://stock.jrj.com.cn/2020/11/13161031275906.shtml",
    "datetime": "2020-11-13 16:10:48",
    "code": "000650"
  },
  {
    "title": "仁和药业：公司工业大麻项目一切正常",
    "href": "http://stock.jrj.com.cn/2020/11/12172031268501.shtml",
    "datetime": "2020-11-12 17:20:41",
    "code": "000650"
  },
  {
    "title": "仁和药业2020年前三季度净利3.7亿下滑15.8% 产品销售受疫情影响收入下降",
    "href": "http://stock.jrj.com.cn/2020/10/29200431159148.shtml",
    "datetime": "2020-10-29 20:04:58",
    "code": "000650"
  },
  {
    "title": "安徽通报药品检查信息 亿帆医药安徽仁和药业已整改",
    "href": "http://stock.jrj.com.cn/2020/10/19175231084781.shtml",
    "datetime": "2020-10-19 17:52:00",
    "code": "000650"
  },
  {
    "title": "仁和药业2020年上半年净利2.42亿下滑25.21% 本期不合并药房网收入",
    "href": "http://stock.jrj.com.cn/2020/08/28185830615870.shtml",
    "datetime": "2020-08-28 18:58:10",
    "code": "000650"
  },
  {
    "title": "仁和药业上半年营收净利双双下降逾两成",
    "href": "http://stock.jrj.com.cn/2020/08/27232130607537.shtml",
    "datetime": "2020-08-27 23:21:29",
    "code": "000650"
  },
  {
    "title": "仁和药业健康相关产品营收超5亿 拟投资大健康产业和工业大麻领域",
    "href": "http://stock.jrj.com.cn/2020/07/07074430163457.shtml",
    "datetime": "2020-07-07 07:44:29",
    "code": "000650"
  },
  {
    "title": "仁和药业拟投资富硒矿泉水项目与中药前处理及提取项目",
    "href": "http://stock.jrj.com.cn/2020/07/03204930136633.shtml",
    "datetime": "2020-07-03 20:49:34",
    "code": "000650"
  },
  {
    "title": "仁和药业拟投资明月仁和矿泉水厂项目和中药前处理及提取项目 计划投资金额合计8.22亿元",
    "href": "http://stock.jrj.com.cn/2020/07/03190730136010.shtml",
    "datetime": "2020-07-03 19:07:04",
    "code": "000650"
  },
  {
    "title": "账上现金21亿 还要融资8亿 这家上市公司打的什么算盘",
    "href": "http://stock.jrj.com.cn/2020/06/30075130093243.shtml",
    "datetime": "2020-06-30 07:51:20",
    "code": "000650"
  },
  {
    "title": "仁和药业非公开发行股票获受理 因账上还有21亿现金此举遭投资者质疑“圈钱”",
    "href": "http://stock.jrj.com.cn/2020/06/29183630088323.shtml",
    "datetime": "2020-06-29 18:36:39",
    "code": "000650"
  },
  {
    "title": "仁和药业2020年一季度盈利1.03亿减少28% 企业经营利润下降",
    "href": "http://stock.jrj.com.cn/2020/04/28222329408373.shtml",
    "datetime": "2020-04-28 22:23:11",
    "code": "000650"
  },
  {
    "title": "仁和药业：2019年年度报告主要财务指标及分配预案",
    "href": "http://stock.jrj.com.cn/2020/04/25013029371283.shtml",
    "datetime": "2020-04-25 01:30:00",
    "code": "000650"
  },
  {
    "title": "仁和药业2019年净利5.38亿 同比增长6.19%",
    "href": "http://stock.jrj.com.cn/2020/04/24232429370769.shtml",
    "datetime": "2020-04-24 23:24:36",
    "code": "000650"
  },
  {
    "title": "仁和药业：拟定增募资不超8.66亿元",
    "href": "http://stock.jrj.com.cn/2020/04/24224129370157.shtml",
    "datetime": "2020-04-24 22:41:32",
    "code": "000650"
  },
  {
    "title": "仁和药业拟定增不超8.66亿元 用于工业大麻项目等",
    "href": "http://stock.jrj.com.cn/2020/04/24180929368658.shtml",
    "datetime": "2020-04-24 18:09:36",
    "code": "000650"
  },
  {
    "title": "仁和药房网第一药房销售不合格化妆品 仁和药业持股",
    "href": "http://stock.jrj.com.cn/2020/04/21153329338847.shtml",
    "datetime": "2020-04-21 15:33:00",
    "code": "000650"
  },
  {
    "title": "仁和药业已捐款捐物总价值超过1000万元",
    "href": "http://stock.jrj.com.cn/2020/02/27144428906295.shtml",
    "datetime": "2020-02-27 14:44:47",
    "code": "000650"
  },
  {
    "title": "仁和药业抗击新型冠状病毒肺炎疫情 总计捐款捐物620万元",
    "href": "http://stock.jrj.com.cn/2020/02/02170928748726.shtml",
    "datetime": "2020-02-02 17:09:32",
    "code": "000650"
  },
  {
    "title": "仁和药业：捐款600万元抗击新型冠状病毒肺炎疫情",
    "href": "http://stock.jrj.com.cn/2020/02/02164828748655.shtml",
    "datetime": "2020-02-02 16:48:05",
    "code": "000650"
  },
  {
    "title": "仁和药业捐款捐物超600万元助力疫情防控",
    "href": "http://stock.jrj.com.cn/2020/01/28200528739756.shtml",
    "datetime": "2020-01-28 20:05:00",
    "code": "000650"
  },
  {
    "title": "仁和药业：有KN95口罩在销售 目前应该已卖脱销",
    "href": "http://stock.jrj.com.cn/2020/01/25142928735169.shtml",
    "datetime": "2020-01-25 14:29:00",
    "code": "000650"
  },
  {
    "title": "仁和药业：苯磺酸氨氯地平片通过仿制药一致性评价",
    "href": "http://stock.jrj.com.cn/2020/01/21162728713705.shtml",
    "datetime": "2020-01-21 16:27:39",
    "code": "000650"
  },
  {
    "title": "仁和药业：子公司苯磺酸氨氯地平片通过仿制药一致性评价",
    "href": "http://stock.jrj.com.cn/2020/01/21162128713677.shtml",
    "datetime": "2020-01-21 16:21:00",
    "code": "000650"
  },
  {
    "title": "仁和药业:公司现有KN95口罩在销售",
    "href": "http://stock.jrj.com.cn/2020/01/20172228706686.shtml",
    "datetime": "2020-01-20 17:22:59",
    "code": "000650"
  },
  {
    "title": "仁和药业第三季度盈利1.16亿 同比下滑22%",
    "href": "http://stock.jrj.com.cn/2019/10/30083528323102.shtml",
    "datetime": "2019-10-30 08:35:33",
    "code": "000650"
  },
  {
    "title": "仁和药业：各项硬件条件允许后 随时可以开始提取大麻二酚的工作",
    "href": "http://stock.jrj.com.cn/2019/10/23155828288322.shtml",
    "datetime": "2019-10-23 15:58:00",
    "code": "000650"
  },
  {
    "title": "仁和药业：大麻收割工作已陆续开展",
    "href": "http://stock.jrj.com.cn/2019/09/02134028075758.shtml",
    "datetime": "2019-09-02 13:40:21",
    "code": "000650"
  },
  {
    "title": "仁和药业：2019年半年度报告主要财务指标",
    "href": "http://stock.jrj.com.cn/2019/08/27210028043013.shtml",
    "datetime": "2019-08-27 21:00:01",
    "code": "000650"
  },
  {
    "title": "仁和药业：上半年净利3.24亿元 同比增长32%",
    "href": "http://stock.jrj.com.cn/2019/08/27184528042318.shtml",
    "datetime": "2019-08-27 18:45:25",
    "code": "000650"
  },
  {
    "title": "仁和药业：220个产品进入国家医保目录",
    "href": "http://stock.jrj.com.cn/2019/08/27184228042300.shtml",
    "datetime": "2019-08-27 18:42:01",
    "code": "000650"
  },
  {
    "title": "仁和药业上半年净利同比增长33%",
    "href": "http://stock.jrj.com.cn/2019/08/27175728042054.shtml",
    "datetime": "2019-08-27 17:57:58",
    "code": "000650"
  },
  {
    "title": "仁和药业2019年上半年盈利3.2亿 开拓新的销售渠道",
    "href": "http://stock.jrj.com.cn/2019/08/27164528041283.shtml",
    "datetime": "2019-08-27 16:45:39",
    "code": "000650"
  },
  {
    "title": "折价剥离亏损子企 仁和药业转型不顺",
    "href": "http://stock.jrj.com.cn/2019/07/09043427811787.shtml",
    "datetime": "2019-07-09 04:34:48",
    "code": "000650"
  },
  {
    "title": "仁和药业：拟转让仁和药房网15%股权",
    "href": "http://stock.jrj.com.cn/2019/06/28161927769901.shtml",
    "datetime": "2019-06-28 16:19:42",
    "code": "000650"
  },
  {
    "title": "仁和药业：拟6870万元转让仁和药房网15%股权",
    "href": "http://stock.jrj.com.cn/2019/06/28161827769898.shtml",
    "datetime": "2019-06-28 16:18:11",
    "code": "000650"
  },
  {
    "title": "仁和药业：1500亩工业大麻长势良好",
    "href": "http://stock.jrj.com.cn/2019/06/04125727662141.shtml",
    "datetime": "2019-06-04 12:57:00",
    "code": "000650"
  },
  {
    "title": "仁和药业：两家全资子公司取得药品GMP证书",
    "href": "http://stock.jrj.com.cn/2019/05/16160027581870.shtml",
    "datetime": "2019-05-16 16:00:00",
    "code": "000650"
  },
  {
    "title": "仁和药业：两家子公司取得药品GMP证书",
    "href": "http://stock.jrj.com.cn/2019/05/16155327581819.shtml",
    "datetime": "2019-05-16 15:53:06",
    "code": "000650"
  },
  {
    "title": "工业大麻概念再度走强 仁和药业、天津磁卡涨停",
    "href": "http://stock.jrj.com.cn/2019/05/08102727541707.shtml",
    "datetime": "2019-05-08 10:27:00",
    "code": "000650"
  },
  {
    "title": "工业大麻再度反抽 天津磁卡、仁和药业封板",
    "href": "http://stock.jrj.com.cn/2019/05/08101727541643.shtml",
    "datetime": "2019-05-08 10:17:21",
    "code": "000650"
  },
  {
    "title": "工业大麻概念再度活跃 仁和药业等涨停",
    "href": "http://stock.jrj.com.cn/2019/05/07095527536237.shtml",
    "datetime": "2019-05-07 09:55:00",
    "code": "000650"
  },
  {
    "title": "工业大麻概念股全线回暖 仁和药业、八菱科技涨停",
    "href": "http://stock.jrj.com.cn/2019/05/07094527536176.shtml",
    "datetime": "2019-05-07 09:45:08",
    "code": "000650"
  },
  {
    "title": "仁和药业一季度净利1.43亿元同比增长14% 现金流量净额为385万元",
    "href": "http://stock.jrj.com.cn/2019/05/06175627530416.shtml",
    "datetime": "2019-05-06 17:56:45",
    "code": "000650"
  },
  {
    "title": "工业大麻概念股低开高走 华茂股份、仁和药业涨停",
    "href": "http://stock.jrj.com.cn/2019/04/30104227513455.shtml",
    "datetime": "2019-04-30 10:42:00",
    "code": "000650"
  },
  {
    "title": "仁和药业去年净利5.06亿同比增长33.20% 总经理张威薪酬64.2万",
    "href": "http://stock.jrj.com.cn/2019/04/26131027490821.shtml",
    "datetime": "2019-04-26 13:10:51",
    "code": "000650"
  },
  {
    "title": "仁和药业：2018年年度报告主要财务指标及分配预案",
    "href": "http://stock.jrj.com.cn/2019/04/25213027483996.shtml",
    "datetime": "2019-04-25 21:30:00",
    "code": "000650"
  },
  {
    "title": "“利好”未出股价先行 仁和药业被深交所追问：谁的嘴不严？",
    "href": "http://stock.jrj.com.cn/2019/04/24080327472066.shtml",
    "datetime": "2019-04-24 08:03:25",
    "code": "000650"
  },
  {
    "title": "曾请周杰伦代言 十倍股仁和药业如今蹭工业大麻续命转型！",
    "href": "http://stock.jrj.com.cn/2019/04/23182327467779.shtml",
    "datetime": "2019-04-23 18:23:55",
    "code": "000650"
  },
  {
    "title": "股价异动之后 仁和药业披露工业大麻框架协议",
    "href": "http://stock.jrj.com.cn/2019/04/22230827458031.shtml",
    "datetime": "2019-04-22 23:08:12",
    "code": "000650"
  },
  {
    "title": "仁和药业:拟合作投建工业大麻综合利用产业示范项目",
    "href": "http://stock.jrj.com.cn/2019/04/22201527456713.shtml",
    "datetime": "2019-04-22 20:15:04",
    "code": "000650"
  },
  {
    "title": "仁和药业：拟合作投建工业大麻综合利用产业示范项目",
    "href": "http://stock.jrj.com.cn/2019/04/22201127456704.shtml",
    "datetime": "2019-04-22 20:11:40",
    "code": "000650"
  },
  {
    "title": "仁和药业拟投资2100万元参与股权投资基金",
    "href": "http://stock.jrj.com.cn/2019/03/04120227114169.shtml",
    "datetime": "2019-03-04 12:02:41",
    "code": "000650"
  },
  {
    "title": "仁和药业：拟3.62亿元对樟树制药实施技改扩产",
    "href": "http://stock.jrj.com.cn/2019/03/01163627106842.shtml",
    "datetime": "2019-03-01 16:36:40",
    "code": "000650"
  },
  {
    "title": "仁和药业：前三季度净利预增45%-60%",
    "href": "http://stock.jrj.com.cn/hotstock/2018/10/10075925179837.shtml",
    "datetime": "2018-10-10 07:59:53",
    "code": "000650"
  },
  {
    "title": "仁和药业：2018年前三季度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2018/10/09171025177611.shtml",
    "datetime": "2018-10-09 17:10:00",
    "code": "000650"
  },
  {
    "title": "仁和药业：预计前三季度盈利同比增长45％ -60％",
    "href": "http://stock.jrj.com.cn/2018/10/09161125177369.shtml",
    "datetime": "2018-10-09 16:11:09",
    "code": "000650"
  },
  {
    "title": "仁和药业：前三季度净利同比预增45%-60%",
    "href": "http://stock.jrj.com.cn/2018/10/09155525177330.shtml",
    "datetime": "2018-10-09 15:55:00",
    "code": "000650"
  },
  {
    "title": "仁和药业：毛利率持续提升 现金流保持良好状态",
    "href": "http://stock.jrj.com.cn/2018/09/06094025055715.shtml",
    "datetime": "2018-09-06 09:40:00",
    "code": "000650"
  },
  {
    "title": "仁和药业：2018年半年度报告主要财务指标",
    "href": "http://stock.jrj.com.cn/2018/08/28203025015539.shtml",
    "datetime": "2018-08-28 20:30:00",
    "code": "000650"
  },
  {
    "title": "仁和药业半年报净利增五成",
    "href": "http://stock.jrj.com.cn/2018/08/28175825014868.shtml",
    "datetime": "2018-08-28 17:58:41",
    "code": "000650"
  },
  {
    "title": "仁和药业：上半年净利预增40%-60%",
    "href": "http://stock.jrj.com.cn/hotstock/2018/07/12075924803723.shtml",
    "datetime": "2018-07-12 07:59:58",
    "code": "000650"
  },
  {
    "title": "仁和药业：主营业务收入增加 上半年净利预增40%-60%",
    "href": "http://stock.jrj.com.cn/2018/07/11163524800436.shtml",
    "datetime": "2018-07-11 16:35:00",
    "code": "000650"
  },
  {
    "title": "[仁和药业]仁和旗下两家子公司被认定为2017高新技术企业",
    "href": "http://stock.jrj.com.cn/2018/06/25000031696498.shtml",
    "datetime": "2018-06-25 00:00:00",
    "code": "000650"
  },
  {
    "title": "[仁和药业]仁和连续四年荣获“中国年度最佳雇主”奖",
    "href": "http://stock.jrj.com.cn/2018/01/24000023997455.shtml",
    "datetime": "2018-01-24 00:00:00",
    "code": "000650"
  },
  {
    "title": "[仁和药业]仁和连续四年荣获“中国年度最佳雇主”奖",
    "href": "http://stock.jrj.com.cn/2018/01/24000031696497.shtml",
    "datetime": "2018-01-24 00:00:00",
    "code": "000650"
  },
  {
    "title": "仁和药业：全资子公司获得药品GMP证书",
    "href": "http://stock.jrj.com.cn/hotstock/2017/12/25075923844728.shtml",
    "datetime": "2017-12-25 07:59:59",
    "code": "000650"
  },
  {
    "title": "仁和药业拟转让叮当医药电子商务有限公司60%股权",
    "href": "http://stock.jrj.com.cn/2017/12/22181623839397.shtml",
    "datetime": "2017-12-22 18:16:40",
    "code": "000650"
  },
  {
    "title": "仁和药业全资子公司获得药品GMP证书",
    "href": "http://stock.jrj.com.cn/2017/12/22175423839164.shtml",
    "datetime": "2017-12-22 17:54:00",
    "code": "000650"
  },
  {
    "title": "[仁和药业]走进仁和 感受仁和 热爱仁和",
    "href": "http://stock.jrj.com.cn/2017/10/10000027948321.shtml",
    "datetime": "2017-10-10 00:00:00",
    "code": "000650"
  },
  {
    "title": "[仁和药业]公司喜获“2017人力资源管理杰出奖”",
    "href": "http://stock.jrj.com.cn/2017/07/19000027948320.shtml",
    "datetime": "2017-07-19 00:00:00",
    "code": "000650"
  },
  {
    "title": "[仁和药业]仁和药业股份有限公司荣获2017中国医药行业人力资源创新大赛优秀案例奖",
    "href": "http://stock.jrj.com.cn/2017/07/19000031696496.shtml",
    "datetime": "2017-07-19 00:00:00",
    "code": "000650"
  },
  {
    "title": "仁和药业控股股东完成减持 减持均价5.60元",
    "href": "http://stock.jrj.com.cn/2017/06/01130922559579.shtml",
    "datetime": "2017-06-01 13:09:40",
    "code": "000650"
  },
  {
    "title": "仁和药业控股股东及其一致行动人减持2.4406％",
    "href": "http://stock.jrj.com.cn/2017/06/01121522559488.shtml",
    "datetime": "2017-06-01 12:15:03",
    "code": "000650"
  },
  {
    "title": "仁和药业控股股东及一致人拟减持不超9%股份",
    "href": "http://stock.jrj.com.cn/2016/10/18154921585928.shtml",
    "datetime": "2016-10-18 15:49:46",
    "code": "000650"
  },
  {
    "title": "终止定增方案 仁和药业折戟互联网业务资本运作",
    "href": "http://stock.jrj.com.cn/2016/09/13052921451095.shtml",
    "datetime": "2016-09-13 05:29:56",
    "code": "000650"
  },
  {
    "title": "仁和药业再获控股股东增持217万股",
    "href": "http://stock.jrj.com.cn/2015/12/09161920211831.shtml",
    "datetime": "2015-12-09 16:19:08",
    "code": "000650"
  },
  {
    "title": "联合200家药企造B2B平台 仁和药业整合大健康产业链",
    "href": "http://stock.jrj.com.cn/2015/01/13021118688430.shtml",
    "datetime": "2015-01-13 02:11:09",
    "code": "000650"
  },
  {
    "title": "仁和药业：2014年度业绩预盈50%-70%",
    "href": "http://stock.jrj.com.cn/hotstock/2015/01/06080018651383.shtml",
    "datetime": "2015-01-06 08:00:06",
    "code": "000650"
  },
  {
    "title": "仁和药业：拟投120万元设立江西药都养生孙公司",
    "href": "http://stock.jrj.com.cn/hotstock/2014/06/09075917363752.shtml",
    "datetime": "2014-06-09 07:59:59",
    "code": "000650"
  },
  {
    "title": "仁和药业终止收购东科制药",
    "href": "http://stock.jrj.com.cn/2013/12/24051516381452.shtml",
    "datetime": "2013-12-24 05:15:08",
    "code": "000650"
  },
  {
    "title": "仁和药业：2800万元并购禹欣药业推进主业扩张",
    "href": "http://stock.jrj.com.cn/hotstock/2013/12/12092516317783.shtml",
    "datetime": "2013-12-12 09:25:16",
    "code": "000650"
  },
  {
    "title": "仁和药业拟2800万收购禹欣药业 增长率67.57%",
    "href": "http://stock.jrj.com.cn/2013/12/11164616313472.shtml",
    "datetime": "2013-12-11 16:46:00",
    "code": "000650"
  },
  {
    "title": "仁和药业收购杨凌麦迪森股权顺利交接",
    "href": "http://stock.jrj.com.cn/2013/07/09115015502296.shtml",
    "datetime": "2013-07-09 11:50:49",
    "code": "000650"
  },
  {
    "title": "澄清公告被指越描越黑 仁和药业股价昨大跌9.12%",
    "href": "http://stock.jrj.com.cn/2013/03/30040115188886.shtml",
    "datetime": "2013-03-30 04:01:50",
    "code": "000650"
  },
  {
    "title": "仁和药业妇炎洁广告被指打擦边球 或诱导消费者",
    "href": "http://stock.jrj.com.cn/2013/03/29140915187778.shtml",
    "datetime": "2013-03-29 14:09:00",
    "code": "000650"
  },
  {
    "title": "“妇炎洁”系列有产品确为“消毒水”",
    "href": "http://stock.jrj.com.cn/2013/03/29095415186949.shtml",
    "datetime": "2013-03-29 09:54:00",
    "code": "000650"
  },
  {
    "title": "仁和药业对“妇炎洁”是消毒水事项发表澄清",
    "href": "http://stock.jrj.com.cn/2013/03/28194215184821.shtml",
    "datetime": "2013-03-28 19:42:15",
    "code": "000650"
  },
  {
    "title": "仁和药业妇炎洁产品遭质疑 被深交所临时停牌",
    "href": "http://stock.jrj.com.cn/2013/03/28173715184650.shtml",
    "datetime": "2013-03-28 17:37:11",
    "code": "000650"
  },
  {
    "title": "仁和药业就优卡丹系列产品质量等问题说明",
    "href": "http://stock.jrj.com.cn/2013/01/28134314998180.shtml",
    "datetime": "2013-01-28 13:43:10",
    "code": "000650"
  },
  {
    "title": "仁和药业发布澄清公告",
    "href": "http://stock.jrj.com.cn/2013/01/24095414983846.shtml",
    "datetime": "2013-01-24 09:54:55",
    "code": "000650"
  },
  {
    "title": "仁和药业：发布股权激励方案修订稿",
    "href": "http://stock.jrj.com.cn/hotstock/2013/01/23102514978704.shtml",
    "datetime": "2013-01-23 10:25:00",
    "code": "000650"
  },
  {
    "title": "仁和药业：推股权激励方案",
    "href": "http://stock.jrj.com.cn/hotstock/2012/12/21080514854783.shtml",
    "datetime": "2012-12-21 08:05:00",
    "code": "000650"
  },
  {
    "title": "仁和药业：大股东承诺增持1%~2%股份",
    "href": "http://stock.jrj.com.cn/2012/05/29053013293305.shtml",
    "datetime": "2012-05-29 05:30:26",
    "code": "000650"
  },
  {
    "title": "优卡丹被禁轻伤仁和药业 基金又一次“躺着中枪”",
    "href": "http://stock.jrj.com.cn/2012/05/25080813261219.shtml",
    "datetime": "2012-05-25 08:08:07",
    "code": "000650"
  },
  {
    "title": "1岁以下婴儿禁用优卡丹 仁和药业复牌重挫",
    "href": "http://stock.jrj.com.cn/2012/05/25070613259788.shtml",
    "datetime": "2012-05-25 07:06:06",
    "code": "000650"
  },
  {
    "title": "仁和药业：1岁内婴儿禁用优卡丹属实",
    "href": "http://stock.jrj.com.cn/2012/05/24084913247620.shtml",
    "datetime": "2012-05-24 08:49:18",
    "code": "000650"
  },
  {
    "title": "1岁以下儿童禁用优卡丹 仁和药业今日临停",
    "href": "http://stock.jrj.com.cn/invest/2012/05/23113813237029.shtml",
    "datetime": "2012-05-23 11:38:10",
    "code": "000650"
  },
  {
    "title": "仁和药业2.88亿收购两药企",
    "href": "http://stock.jrj.com.cn/2012/04/26100012925063.shtml",
    "datetime": "2012-04-26 10:00:40",
    "code": "000650"
  },
  {
    "title": "仁和药业：定向增发获批 沿着整合之路前行",
    "href": "http://stock.jrj.com.cn/hotstock/2012/02/15204512256563.shtml",
    "datetime": "2012-02-15 20:45:38",
    "code": "000650"
  },
  {
    "title": "仁和药业拟设立南昌分公司",
    "href": "http://stock.jrj.com.cn/2011/12/21191011887511.shtml",
    "datetime": "2011-12-21 19:10:45",
    "code": "000650"
  },
  {
    "title": "仁和药业：再调增发方案 大股东资产“自降身价”",
    "href": "http://stock.jrj.com.cn/2011/11/18032311587307.shtml",
    "datetime": "2011-11-18 03:23:48",
    "code": "000650"
  },
  {
    "title": "仁和药业定增募资缩水3亿",
    "href": "http://stock.jrj.com.cn/2011/11/18002411586047.shtml",
    "datetime": "2011-11-18 00:24:44",
    "code": "000650"
  },
  {
    "title": "仁和药业：业绩稳定高速增长的OTC一线明星",
    "href": "http://stock.jrj.com.cn/hotstock/2011/06/07133210141830.shtml",
    "datetime": "2011-06-07 13:32:20",
    "code": "000650"
  },
  {
    "title": "仁和药业：营销仍有提升空间 推荐评级",
    "href": "http://stock.jrj.com.cn/hotstock/2011/03/3113219618820.shtml",
    "datetime": "2011-03-31 13:21:02",
    "code": "000650"
  },
  {
    "title": "仁和药业：定增募资9亿 整合启幕",
    "href": "http://stock.jrj.com.cn/2011/03/0301209342260.shtml",
    "datetime": "2011-03-03 01:20:52",
    "code": "000650"
  },
  {
    "title": "仁和药业：集团兑现承诺 闪亮制药注入",
    "href": "http://stock.jrj.com.cn/2010/10/2500478399062.shtml",
    "datetime": "2010-10-25 00:47:25",
    "code": "000650"
  },
  {
    "title": "仁和药业：大股东履约 将闪亮制药收入囊中",
    "href": "http://stock.jrj.com.cn/2010/10/2311248397585.shtml",
    "datetime": "2010-10-23 11:24:32",
    "code": "000650"
  },
  {
    "title": "仁和药业：大股东将注入闪亮制药",
    "href": "http://stock.jrj.com.cn/2010/10/2000168367716.shtml",
    "datetime": "2010-10-20 00:16:39",
    "code": "000650"
  },
  {
    "title": "仁和药业：因重大事项停牌",
    "href": "http://stock.jrj.com.cn/2010/10/1907168360462.shtml",
    "datetime": "2010-10-19 07:16:20",
    "code": "000650"
  },
  {
    "title": "仁和药业：拟参与江西制药改制",
    "href": "http://stock.jrj.com.cn/2010/09/1406308162899.shtml",
    "datetime": "2010-09-14 06:30:58",
    "code": "000650"
  },
  {
    "title": "仁和药业：定向增发股东获利丰厚",
    "href": "http://stock.jrj.com.cn/2010/07/2713047822996.shtml",
    "datetime": "2010-07-27 13:04:27",
    "code": "000650"
  },
  {
    "title": "仁和药业浮盈6亿 “洗衣专家”纳爱斯成定增大户",
    "href": "http://stock.jrj.com.cn/2010/07/2705027818173.shtml",
    "datetime": "2010-07-27 05:02:57",
    "code": "000650"
  }
]